PRK

Chromocell Issues Letter to Stockholders from Chief Executive Officer

Retrieved on: 
Tuesday, April 9, 2024
Erythromelalgia, Consultant, Toxicity, ChromeOS, Abrasion (medical), Letter, Uveitis, Growth, Opioid, Neuropathic pain, Incidence, Physiology, Patient, NAV, Mortality, IPO, Human, Rash, Outline, Lawyer, Annual report, CHRO, PRK, Pain, Glaucoma, NSAID, Therapy, Family, Photorefractive keratectomy, FDA, Liver, Food, Pharmaceutical industry

We transferred $2.2 million in liabilities to Chromocell Corporation in exchange for 2,600 shares of Series C Convertible Redeemable Preferred Stock (“Series C Preferred Stock”).

Key Points: 
  • We transferred $2.2 million in liabilities to Chromocell Corporation in exchange for 2,600 shares of Series C Convertible Redeemable Preferred Stock (“Series C Preferred Stock”).
  • Our CEO has agreed to further defer a considerable portion of his accrued compensation, affirming the belief in Chromocell’s mission.
  • We truly feel that our IPO and recent therapeutic development activities have positioned Chromocell for long term growth and success.
  • I wish to thank you for your support and remain a resource to each of you as we move forward.

SightMD Earns Double Win at Best of the Boro 2024 Competition

Retrieved on: 
Thursday, March 28, 2024
Ophthalmology, TimesLedger Newspapers, Patient, Surgeon, Digital newspaper, PRK, Medical device

HAUPPAUGE, N.Y., March 28, 2024 /PRNewswire-PRWeb/ -- SightMD, one of the leading providers of comprehensive eye care services in New York, has proudly announced its double win in the Best of the Boro 2024 competition. The renowned practice has secured top honors in both the Lasik Surgery Practice and Ophthalmologist categories, further solidifying its commitment to excellence in eye care.

Key Points: 
  • SightMD, one of the leading providers of comprehensive eye care services in New York, has proudly announced its double win in the Best of the Boro 2024 competition.
  • HAUPPAUGE, N.Y., March 28, 2024 /PRNewswire-PRWeb/ -- SightMD, one of the leading providers of comprehensive eye care services in New York, has proudly announced its double win in the Best of the Boro 2024 competition .
  • The Best of the Boro competition, organized by the Queens Courier, is an annual event that recognizes outstanding businesses and services in Queens, New York.
  • As the winner of the Best of the Boro 2024 competition in the Lasik Surgery Practice and Ophthalmologist categories, SightMD looks forward to continuing its tradition of excellence and serving the eye care needs of the Queens community.

KBRA Releases Research – CMBS Loan Performance Trends: January 2024

Retrieved on: 
Monday, January 29, 2024
Banking, Professional Services, Finance, KBRA, CMBS, PRK, Loss, Veritas, LL

KBRA releases a report on U.S. commercial mortgage-backed securities (CMBS) loan performance trends observed in the January 2024 servicer reporting period.

Key Points: 
  • KBRA releases a report on U.S. commercial mortgage-backed securities (CMBS) loan performance trends observed in the January 2024 servicer reporting period.
  • The delinquency rate among KBRA-rated U.S. commercial mortgage-backed securities (CMBS) in January meaningfully climbed from December, rising almost 10% to 4.61%.
  • The total delinquent and specially serviced loan rate (distress rate) also jumped more than 11% to 7.39%.
  • In this report, KBRA provides observations across our $317.3 billion rated universe of U.S. private label CMBS including conduits, single-asset single borrower (SASB), and large loan (LL) transactions.

STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision

Retrieved on: 
Tuesday, January 23, 2024
General Health, Surgery, Medical Devices, Health, Optical, MD, Ophthalmology, PIB, Contact, ASCRS, Presbyopia, EVO, Multimedia, Astigmatism, Near-sightedness, Society, Dioptre, Quality, PRK, Marketing, Surgeon, Lens, ICL, Refractive surgery, Nave, Cataract

View the full release here: https://www.businesswire.com/news/home/20240123947715/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240123947715/en/
    STAAR Surgical and SharpeVision will collaborate on marketing and education activities to elevate awareness of EVO ICL and significantly increase availability of the lenses to all qualified patients in SharpeVision clinics.
  • STAAR Surgical will also provide additional practice development and clinical support.
  • “We are pleased to announce SharpeVision as a new partner under our U.S. Highway 93 go-to-market program initiated in October 2023.
  • Naves, J. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery.

Dr. George Waring, IV Agrees to Serve as the Chairman of the Trusted LASIK Surgeons™ Advisory Board

Retrieved on: 
Monday, December 11, 2023
Ophthalmology, Surgeon, Patient, Mission, Science, FACS, Trust (social science), Cataract, MD, Intraocular lens, Nation, RK, Medical device, PRK, LASIK

CHARLESON, S.C., Dec. 11, 2023 /PRNewswire-PRWeb/ -- Trusted LASIK Surgeons™- Charleston, SC - December 11, 2023. Trusted LASIK Surgeons™, the premier LASIK, cataract and refractive surgeon directory service, is pleased to announce that Charleston LASIK Surgeon, Dr. George O. Waring, IV, MD, FACS, founder of the Waring Vision Institute, has agreed to serve as the Chairman of its advisory board. Dr. Waring is trusted by the ophthalmology community as one of the top experts in all types of laser vision correction, cataract and refractive surgery, including LASIK, premium lens implants (IOLs), EVO-ICLs and corneal inlay procedures.

Key Points: 
  • Trusted LASIK Surgeons™ is pleased to announce Dr. George O. Waring, IV, of the Waring Vision Institute, as the Chairman of its advisory board.
  • Trusted LASIK Surgeons™, the premier LASIK, cataract and refractive surgeon directory service, is pleased to announce that Charleston LASIK Surgeon , Dr. George O. Waring, IV, MD, FACS , founder of the Waring Vision Institute, has agreed to serve as the Chairman of its advisory board.
  • As Chairman of the Trusted LASIK Surgeons™ advisory board, Dr. Waring will help ensure that the quality of content on our website meets the high standards first set by Dr. James J. Salz, the co-founder of Trusted LASIK Surgeons™, who passed away in March 2022.
  • As a result, Trusted LASIK Surgeons™ brings patients together with the top refractive surgeons in the discipline."

Unifeye Vision Partners Expands into Los Angeles, Ventura County, and the Central Coast of California

Retrieved on: 
Tuesday, September 19, 2023
Paragon, Retina, Glaucoma, Partnership, Cornea, ADV, Cataract, Ophthalmology, Optometry, Patient, Physician, Central Coast, UVP, Health insurance, Nursing, Management, PRK, Central California

DALLAS, Sept. 19, 2023 /PRNewswire/ -- Unifeye Vision Partners ("UVP"), a leading network of comprehensive eye care providers, today announced the completion of a strategic partnership with Insight Vision Group, based in Los Angeles, California.  This innovative, patient-centric ophthalmology group includes two practices, DLV Vision and ADV Vision. Together, they add 10 new clinics and 2 new ambulatory surgery centers to UVP's growing presence across the State of California and mark UVP's entry into the Los Angeles market.

Key Points: 
  • DALLAS, Sept. 19, 2023 /PRNewswire/ -- Unifeye Vision Partners ("UVP"), a leading network of comprehensive eye care providers, today announced the completion of a strategic partnership with Insight Vision Group , based in Los Angeles, California.
  • Unifeye Vision Partners adds Insight Vision Group, expanding into Los Angeles and the Central Coast of California
    Providing custom vision solutions with high-quality patient care, Insight Vision Group's talented physicians utilize the latest technology to create a seamless eye care journey for the full suite of vision diagnosis and treatment options including cataract, LASIK, PRK, corneal, glaucoma, retina, dry eye services, and general ophthalmology.
  • Founded in 1996 by Dr. Paul J. Dougherty, DLV Vision serves patients across the greater Los Angeles area.
  • The Los Angeles office of Brown Gibbons Lang & Company served as Insight Vision Group's exclusive mergers and acquisitions advisor in this transaction.

Prominent Comprehensive Ophthalmologist, Dr. Brett J. Karlik, Joins OCLI Vision's McMurray Location

Retrieved on: 
Thursday, September 7, 2023
Diabetic retinopathy, Duquesne University, SLT, Ophthalmology, McMurray, Focal, Nassau University Medical Center, Patient, PRP, Happiness, Knowledge, Health, Medical device, Nursing, LASIK, PRK, MD

GARDEN CITY, N.Y., Sept. 7, 2023 /PRNewswire-PRWeb/ -- OCLI Vision is pleased to announce the addition of Brett J. Karlik, MD, to their esteemed team of eye care professionals. Dr. Karlik is a highly skilled Comprehensive Ophthalmologist with a diverse range of expertise in various ophthalmic procedures. He commenced his practice at OCLI Vision's McMurray location in Pennsylvania on August 1, 2023.

Key Points: 
  • OCLI Vision has welcomed Dr. Brett J. Karlik, a skilled Comprehensive Ophthalmologist, to its team at the McMurray location in Pennsylvania as of August 1, 2023.
  • He commenced his practice at OCLI Vision's McMurray location in Pennsylvania on August 1, 2023.
  • Patients seeking expert comprehensive eye care can now benefit from Dr. Karlik's exceptional services at the McMurray location.
  • To schedule an appointment with Dr. Brett J. Karlik or to learn more about the comprehensive eye care services provided at OCLI Vision, please visit ocli.net.

Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting

Retrieved on: 
Wednesday, September 6, 2023
Health, Surgery, General Health, Research, Science, Pharmaceutical, Optical, Cataract surgery, Surgeon, Very-small-aperture terminal, Refractive surgery, Aperture, Safety, Bausch, DRS, PRK, Bausch & Lomb, Toronto Congress Centre, Physician, CEST, Range, European Society for Primary Immunodeficiencies, Cataract, IOL, NYSE, Combination, MIMS, Telescope, Hospital, Dentistry, Silviculture, Medical device, Patient

Safety and performance results of the enVista® ENVY, an investigational premium IOL

Key Points: 
  • Safety and performance results of the enVista® ENVY, an investigational premium IOL
    Refractive outcomes of a low 0.90 diameter cylinder for the investigational enVista Toric IOL.
  • Bausch + Lomb will also host several educational and networking events during the meeting.
  • Other presentations featuring the company’s latest surgical technology will take place in the Bausch + Lomb booth, and Bausch + Lomb will host a Lift Off Celebration event to mark its 170th anniversary.
  • “Evaluation of Visual Outcomes in Patients with Complex Corneas Implanted with the IC-8 IOL.” J. Mehta et al.

SightMD Physicians named 2023 Super Doctors® and Rising Stars

Retrieved on: 
Monday, May 15, 2023
Medicine, Editorial board, Paratriathlon, DO, MD, Patient, Premature, Neuro-ophthalmology, Forehead, World Golf Village, Corneal transplantation, Face, Friends, Orbit, Research, Rockville Centre, New York, Super, Uveitis, Optic nerve, Entrepreneurship, New York Eye and Ear Infirmary, Textbook, Cataract, Abstract, Osteopathic medicine in the United States, Good Samaritan Hospital, Eye, Eyelid, Publishing, Clinical research, Engineering, Microsurgery, Family, Surgeon, CXL, Education, Cross-link, Physician, Hall, Fellow, Pleasure, Rare-earth element, Medical device, Nursing, Dentistry, Veterinary medicine, Ophthalmology, Glaucoma, PRK, Retina, LASIK

HAUPPAUGE, N.Y., May 15, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.

Key Points: 
  • SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.
  • HAUPPAUGE, N.Y., May 15, 2023 /PRNewswire-PRWeb/ -- SightMD is excited to announce the growing list of providers that have been named on the 2023 "Super Doctor" and "Super Doctors Rising Stars" lists.
  • said Dr. Baharestani "It is an honor to provide our patients with the highest level oculoplastic surgery services at SightMD."
  • "I am truly honored to be selected as a Super Doctors Rising Star for the 5th year in a row."

EyeCare Partners’ Leadership and Clinical Research to be Showcased at American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Retrieved on: 
Thursday, May 4, 2023
Surgery, Health, Science, Research, Optical, Dark, Partner, Eye drop, Ophthalmology, ASCRS, Varenicline, Telecanthus, Patient satisfaction, Ciclosporin, Patient experience, ECP, Presbyopia, Ageing, Randomness, Cataract, Legacy Devers Eye Institute, Wonderful, Manual, Refractive surgery, Endothelium, Ocular hypertension, American Society of Cataract and Refractive Surgery, Somatosensory system, Ketamine, Contact lens, Political moderate, Learning curve, Pilocarpine, DED, Retina, Midazolam, Phacoemulsification, Corneal neovascularization, Loteprednol, Immunosuppression, Physician, Pivotal, Society, Treatment, Rejuvenation, Veterinary medicine, Nursing, Hospital, Telescopic sight, Medical imaging, Pharmaceutical industry, Casino, PRK, Tacrolimus, LASIK, Creatinine, History, Patient

The annual meeting will take place May 5-8, 2023, in San Diego.

Key Points: 
  • The annual meeting will take place May 5-8, 2023, in San Diego.
  • The breadth of topics being presented at ASCRS by ECP physicians emphasizes the company’s culture of innovation and continuous learning.
  • It also underscores the possibility of a career “third pathway” which allows physicians to conduct industry-leading research while also continuing to build a clinical practice.
  • “EyeCare Partners has a strong representation of ophthalmologists presenting research at ASCRS this year, in addition to one of our specialists, Dr. Elizabeth Yeu, serving as the incoming president of ASCRS,” said David Clark, CEO of EyeCare Partners.